Funding Received
$7 Million in 1 Round from 3 Investors
Most Recent Funding
$7 Million Series A on February 22, 2008
Headquarters:
Branford, CT
Description:
Affomix develops technology for the automated, high-throughput selection of human monoclonal antibodies.
Founders:
Michael I. Sherman, Michael Sherman
Categories:
Biotechnology
Website:
http://www.affomix.com

Detailed Description

Update

Affomix has proprietary technology for rapid, automated, high-throughput selection of human monoclonal antibodies (mAbs). Their mission is to commercialize proprietary mAbs, mAb microarrays and mAb libraries for research, drug discovery, diagnostic and therapeutic applications, with a particular focus on the use of their mAbs for sensitive and accurate measurement of very large numbers of proteins in biological samples.

Current Team (1)

Update

Past Team (2)

Update

Funding Rounds (1) - $7M

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    688 East Main Street

    Branford, CT 06405

    USA

Images (1)

Update
  • A05bf03089b38f05a175dc3744aad34e